Beranda › Penyakit Hati Steatotik › California
Uji klinis Penyakit Hati Steatotik di California
22 studi untuk Penyakit Hati Steatotik mencari peserta di lokasi di California.
Kota di California
- San Diego14 studi
- Pasadena8 studi
- Los Angeles8 studi
- Lancaster7 studi
- Orange5 studi
- San Francisco5 studi
- Huntington Beach5 studi
- Fresno5 studi
- Rialto5 studi
- Long Beach4 studi
- Folsom4 studi
- Escondido3 studi
- Sacramento3 studi
- Santa Maria3 studi
- Simi Valley3 studi
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Camarillo
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- dan 10 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- 89bio Clinical Study Site, Escondido
- dan 13 lainnya
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06318169A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Folsom
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Folsom
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07701993A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Southern California Research Center, Coronado
- California Liver Research Institute, Pasadena
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- University of California San Diego NAFLD Research Center, La Jolla
- Keck Medical Center of USC, Los Angeles
- LAC + USC Medical Center, Los Angeles
- dan 2 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05832229A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Southern California Research Center, Coronado
- Om Research Llc, Lancaster
- Clinnova Research Solutions, Orange
- dan 3 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- San Fernando Valley Health Institute, Canoga Park
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Fresno Clinical Research Center, Fresno
- dan 11 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Coronado
- Akero Clinical Study Site, Escondido
- Akero Clinical Study Site, Folsom
- dan 13 lainnya
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Arcadia
- GSK Investigational Site, Covina
- GSK Investigational Site, Los Angeles
- dan 3 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Om Research, Apple Valley
- ARK Clinical Research - Fountain Valley, Fountain Valley
- UCSD Medical Center, La Jolla
- dan 4 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07288138A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Coronado
- GSK Investigational Site, Lancaster
- GSK Investigational Site, Los Angeles
- dan 3 lainnya
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Arcadia
- GSK Investigational Site, Covina
- GSK Investigational Site, Folsom
- dan 6 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Fresno
- GSK Investigational Site, Lancaster
- GSK Investigational Site, Pasadena
- dan 2 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT06920043A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- GSK Investigational Site, Rialto
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT07358546Bicalutamide Therapy in Young Women With NAFLD and PCOS
- University of California San Francisco, San Francisco
Menerima pesertaFase 1
Usia 18 hingga 42 · Wanita · Diperbarui 29 Mei 2026 · NCT05979389A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Velocity Clinical research, Los Angeles
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT05648214Androgens and NAFLD Longitudinal Cohort Study
- University of California San Francisco, San Francisco
Menerima pesertaStudi observasional
Usia 18 hingga 42 · Wanita · Diperbarui 13 Apr 2026 · NCT06124261Accurate Point of Care Liver Disease Diagnostics (Phase 2)
- University of California San Diego, La Jolla
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT07518784Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
- University of California San Diego, La Jolla
Menerima pesertaStudi observasional
Usia 9 hingga 18 · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT06706856Implementing Food Referrals for Equity and Sustained Health
- Rady Children's Hospital San Diego, San Diego
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 19 Nov 2025 · NCT06661538Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Stanford University, Stanford
Menerima pesertaSukarelawan sehat diterima
Usia 35 hingga 65 · Semua jenis kelamin · Diperbarui 4 Des 2024 · NCT05165706Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.